Press Releases

May 17, 2022
IN8bio Announces Data Emerging from its Recently Unveiled Gamma-Delta T cell “Off-the-Shelf” Induced Pluripotent Stem Cell Platform
PDF Version
May 12, 2022
IN8bio Reports First Quarter 2022 Financial Results and Provides Corporate Update
PDF Version
May 5, 2022
IN8bio Unveils Induced Pluripotent Stem Cell (iPSC) Platform at ASGCT 25th Annual Meeting
PDF Version
May 4, 2022
IN8bio to Present at May Investor and Scientific Conferences
PDF Version
April 13, 2022
IN8bio Continues to Build on its Clinical and Regulatory Team with Two Key Appointments
PDF Version